Regional

Research from anesthesiology, pain and critical care journals, sourced from PubMed.

Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.

AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.

Last successful paper check: 16 Nov 2026 17:18 UTC. 0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
Article Interv Pain Med Published 21 Sep 2026
Percutaneous brachial plexus peripheral nerve stimulation for cancer-related upper extremity pain: a novel technical approach.
AI-generated abstract summary · verify against the original paper
  • This case report describes one patient with metastatic lung adenocarcinoma and refractory pain from a pathologic humeral fracture, hospitalized for treatment.
  • Temporary percutaneous brachial plexus peripheral nerve stimulation was placed using a dual-lead, ultrasound-guided, parallel subclavicular technique called DAVIS.
  • The patient stopped all opioid use and reported substantial, sustained pain relief after implantation; no numerical pain or opioid measures are reported in the abstract.
  • The authors conclude brachial plexus PNS is promising for extremity oncologic pain and that dual-lead parallel placement may help in anatomically complex or opioid-refractory cases.
PubMed indexed 3 Oct 2026 Imported 9 Nov 2026 Nguyen L et al. Publisher Chronic painRegional
RCT Reg Anesth Pain Med Published 18 Sep 2026
Real-time AI-assisted nerve tracking for ultrasound-guided nerve identification: a prospective randomized trial.
AI-generated abstract summary · verify against the original paper
  • Prospective randomized trial of 80 ultrasound novices (60 medical students, 20 anesthesiology residents), with 78 completing, comparing B-mode training alone against AI-assisted nerve tracking training.
  • Participants received a standardized lecture and 10-minute hands-on session, then were assessed with the AI function disabled; the AI group used the NerveTrack real-time tracking system.
  • First-attempt independent identification did not differ for the median nerve (57.5% vs 65.8%, RR 1.14, 95% CI 0.81 to 1.62, p=0.452) or the brachial plexus (35.0% vs 42.1%, RR 1.20, 95% CI 0.68 to 2.11, p=0.519).
  • The AI-assisted group reported higher brachial plexus confidence after additional AI-assisted training (4.7±0.5 vs 4.4±0.9, p=0.046), while the authors conclude brief AI training did not improve immediate independent identification.
PubMed indexed 18 Sep 2026 Imported 9 Nov 2026 Kim J et al. Publisher Regional
Meta-analysis Eur J Anaesthesiol Published 17 Sep 2026
Comparison of the efficacy of different interventions for rebound pain after brachial plexus block in upper extremity surgery: A systematic review and network meta-analysis.
AI-generated abstract summary · verify against the original paper
  • Bayesian network meta-analysis of 22 RCTs (1,699 patients) on preventing and treating rebound pain after brachial plexus block for upper-limb surgery.
  • Six interventions were compared against placebo: dexamethasone, esketamine, dexmedetomidine, liposomal bupivacaine, continuous nerve block and combined nerve block.
  • Versus placebo, dexamethasone (OR 0.22, 95% CI 0.11 to 0.42), dexmedetomidine (OR 0.23, 0.08 to 0.68) and continuous nerve block (OR 0.04, 0.01 to 0.33) reduced rebound pain incidence.
  • Dexamethasone and continuous block lowered 12-hour pain scores, and combined block lowered 24-hour scores; the authors call the evidence exploratory and hypothesis-generating.
PubMed indexed 17 Sep 2026 Imported 9 Nov 2026 Ma W et al. Publisher Regional
RCT Reg Anesth Pain Med Published 15 Sep 2026
Transcutaneous auricular vagus nerve stimulation to prevent rebound pain after interscalene block for arthroscopic shoulder surgery.
AI-generated abstract summary · verify against the original paper
  • Single-center, randomized, participant- and assessor-blinded, sham-controlled trial of 120 adults undergoing arthroscopic shoulder surgery with single-shot interscalene block.
  • Patients received either active transcutaneous auricular vagus nerve stimulation or sham stimulation, applied perioperatively and on postoperative days 1 and 2.
  • Rebound pain occurred in 20.0% of the taVNS group versus 43.3% of the sham group (absolute risk reduction 23.3%, 95% CI 7.2% to 39.5%; p=0.006).
  • Secondary results showed modestly lower pain scores and better recovery and sleep, with no added adverse events; sufentanil use did not differ significantly.
PubMed indexed 15 Sep 2026 Imported 9 Nov 2026 Zhang J et al. Publisher Regional
Review Skeletal Radiol Published 15 Sep 2026
Local anesthetic selection for spine and large joint radiofrequency ablation: a practical review for the musculoskeletal radiologist.
AI-generated abstract summary · verify against the original paper
  • This narrative practical review synthesizes indirect pharmacological and adjacent procedural evidence, with no dedicated comparative trial of local anesthetics within RFA.
  • It suggests lidocaine 1% as a default for skin and track anesthesia, and avoiding lidocaine 2% near the target nerve where stimulation testing is done, based on mechanistic reasoning.
  • Across five randomized trials outside interventional pain settings, premixing lidocaine and bupivacaine showed no onset advantage over bupivacaine alone and sometimes shortened duration.
  • The authors conclude these considerations are provisional and call for prospective studies, and they provide an allergy substitution pathway centered on formal allergist evaluation.
PubMed indexed 15 Sep 2026 Imported 9 Nov 2026 Gonzalez FM et al. Publisher Chronic painRegional
Article Int J Obstet Anesth Published 11 Sep 2026
Spinal cord stimulation in pregnancy and peripartum management and maternal and device outcomes: a retrospective cohort study (2015-2026).
AI-generated abstract summary · verify against the original paper
  • Retrospective cohort at two affiliate hospitals (2015-2026) of eight patients with a pre-existing spinal cord stimulator, covering 12 deliveries.
  • Neuraxial labor analgesia or cesarean anesthesia was attempted in every delivery, with the cohort including both successes and failures.
  • A reportedly successful block was achieved in 10 cases, both failures occurred in emergencies, and no dural puncture, new deficit, LAST, ICU admission, or device complication was recorded.
  • Intrapartum device status was documented in only three of 12 deliveries, so the authors conclude that peripartum device management was inconsistently documented.
PubMed indexed 16 Sep 2026 Imported 9 Nov 2026 Daniels M et al. Publisher Chronic painObstetricRegional
Article Reg Anesth Pain Med Published 11 Sep 2026
Ultrasound-guided percutaneous temporary vagus nerve stimulation for refractory post-traumatic chronic pain and post-traumatic stress disorder (PTSD): first reported case and implantation technique.
AI-generated abstract summary · verify against the original paper
  • Single-patient case report of a woman in her late 20s with refractory post-traumatic chronic pain, PTSD, headaches, and occipital neuralgia after repeated traumatic brain injuries.
  • She received an ultrasound-guided percutaneous temporary left vagus nerve stimulator for 60 days after conservative management failed.
  • Pain fell from 10/10 to 0/10 over eight weeks, and the analgesic benefit was reported as sustained at 4-month follow-up.
  • PCL-5 PTSD scores rose during follow-up, and no pre-procedure PCL-5 baseline was available to judge the overall change.
PubMed indexed 11 Sep 2026 Imported 9 Nov 2026 Elsharkawy H et al. Publisher Chronic painRegional
Article Int J Obstet Anesth Published 10 Sep 2026
Anesthetic management of cesarean delivery in patients with acute fatty liver of pregnancy: a retrospective single-center study (2018-2026).
AI-generated abstract summary · verify against the original paper
  • Retrospective single-center review of 15 patients with acute fatty liver of pregnancy who had cesarean delivery between 2018 and 2026, after excluding 5 of 20 identified.
  • Eleven received single-shot spinal anesthesia, one continuous spinal (for placenta accreta spectrum), and three general anesthesia (for severe disease, thrombocytopenia, or emergency indications).
  • One general anesthesia patient died 16 h after delivery, and one spinal patient had postpartum encephalopathy with transient diabetes insipidus; all spinal patients recovered normal sensory and motor function.
  • The authors conclude single-shot spinal anesthesia was feasible, while general anesthesia was used for more severe disease or emergency obstetric indications.
PubMed indexed 16 Sep 2026 Imported 9 Nov 2026 Tawfik MM et al. Publisher ObstetricRegional
Article Reg Anesth Pain Med Published 10 Sep 2026
Evaluation of a mental health screening tool to determine the need for psychological interview for patients offered neuromodulation implant therapies for pain.
AI-generated abstract summary · verify against the original paper
  • Prospective observational cohort of 171 patients at one center undergoing spinal cord stimulation trials (2017–2021), comparing screening-based fast track with formal psychological assessment.
  • Patients who screened negative on validated questionnaires and a mental health checklist went straight to trial (FT), while screen-positive patients saw a psychologist (AP).
  • Trial-to-implant rates were similar (72% AP vs 70% FT, p=0.811), and 1-year responder rates were comparable (53% AP vs 60% FT, p=0.927).
  • Higher baseline pain intensity and tricyclic antidepressant use were associated with implant failure, while pain duration over 10 years was associated with success; the authors conclude the tool allows bypassing routine assessment without compromising outcomes.
PubMed indexed 4 Mar 2026 Imported 9 Nov 2026 Xiao MZX et al. Publisher Chronic painRegional
RCT Pain Published 9 Sep 2026
Pharmacological modulation of peripheral nerve excitability: a novel way to investigate sodium channel subtypes in humans.
AI-generated abstract summary · verify against the original paper
  • Randomized, placebo-controlled, double-blinded crossover-style study in 20 healthy participants testing topical drugs on peripheral sensory nerve excitability.
  • Compared topical 5% lidocaine, 10% phenytoin and 2% mepyramine against placebo, measuring perception threshold changes with a new sodium channel nociceptor testing protocol.
  • Perception threshold increases differed between drugs (P < 0.01) and versus placebo (P < 0.01), except phenytoin (P = 0.22), which did not differ significantly.
  • Authors report a computational model suggesting lidocaine and mepyramine alter Nav1.7, 1.8 and 1.9 currents differently, supporting the protocol for probing subtype-specific pharmacology.
PubMed indexed 17 Sep 2026 Imported 9 Nov 2026 Andresen T et al. Publisher Chronic painRegional
Observational Anaesthesia Published 8 Sep 2026
Pericapsular nerve group block with phenol for non-operative hip fracture management in patients living with frailty: a prospective multicentre cohort study.
AI-generated abstract summary · verify against the original paper
  • A prospective multicentre cohort at seven Dutch hospitals enrolled 103 frail patients (mean age 87) who chose non-operative management of hip fracture.
  • All patients received an ultrasound-guided pericapsular nerve group block with phenol 6% (mean 10 ml), with a second needle needed in 14%; there was no comparator group.
  • At 1 week, 34/36 (94%) reported acceptable pain at rest, and 24/53 (45%) could transfer from bed to chair.
  • Three-month mortality was 72/91 (79%), with median survival of 9 days; the authors describe the block as an effective add-on analgesic.
PubMed indexed 9 Sep 2026 Smits RJH et al. Publisher Perioperative medicineRegional
Review Reg Anesth Pain Med Published 8 Sep 2026
Intrathecal drug delivery systems: an overview of cost-effectiveness evidence.
AI-generated abstract summary · verify against the original paper
  • This overview reviews health economic principles and published full and partial economic evaluations of intrathecal drug delivery (ITDD) systems across cancer pain, chronic non-cancer pain, and spasticity.
  • ITDD is compared with conventional management strategies, and the analyses span varying perspectives and healthcare settings.
  • Most analyses suggest ITDD is cost-effective, particularly for cancer-related pain and spasticity, though the authors caution that findings rest on heterogeneous methods and often small or uncontrolled effectiveness data.
  • Evidence for chronic non-cancer pain is sparse and inconsistent, and the authors call for comparative effectiveness research and long-term economic modeling.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Duarte RV et al. Publisher Chronic painRegional
Article Reg Anesth Pain Med Published 8 Sep 2026
Diagnosis and management of hypersensitivity to titanium in implanted intrathecal pain pump: a case report.
AI-generated abstract summary · verify against the original paper
  • This case report describes one patient with prior lumbar spine surgery and refractory low back pain who had two intrathecal pump explants for suspected infection.
  • The patient was ultimately diagnosed with type IV titanium hypersensitivity, and the pump was reimplanted after being encased in an expanded polytetrafluoroethylene (ePTFE) fabric pouch.
  • The reimplanted intrathecal drug delivery system was reported as successful, with no rejection described.
  • The authors conclude that device-component hypersensitivity should be considered in recurrent or unexplained pump site complications, and that an ePTFE pouch may allow reimplantation.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Kiernan J et al. Publisher Chronic painRegional
Review Reg Anesth Pain Med Published 8 Sep 2026
Implanted intrathecal drug delivery systems: a narrative review for the perioperative, obstetric, and intensive care anesthesiologist.
AI-generated abstract summary · verify against the original paper
  • This narrative review draws on PubMed, Google Scholar, reference lists, and intrathecal pump device manuals to cover perioperative, obstetric, and ICU care of patients with implanted intrathecal drug delivery systems.
  • It is organized into five sections: intrathecal pharmacology, implantation considerations, perioperative care, neuraxial anesthesia, and device-related safety concerns.
  • Where evidence is limited, the authors supplement the literature with expert opinion, so some recommendations rest on consensus rather than data.
  • The authors highlight intrathecal medications, their behavior under MRI, and precautions before any neuraxial access in these patients.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Jenkinson R et al. Publisher Critical careObstetricPerioperative medicineRegional
Article Reg Anesth Pain Med Published 8 Sep 2026
Sequential flex mode for intrathecal infusion after continuous mode failure: a retrospective follow-up study for refractory cancer pain management.
AI-generated abstract summary · verify against the original paper
  • A retrospective single-center study of 53 patients with refractory cancer pain on intrathecal infusion systems, where the sequential flex mode was used after continuous mode failed.
  • The sequential flex mode uses a basal flow with large boluses and was compared with the prior continuous flow rate mode in the same patients.
  • 71.7% ± 6.43% of patients achieved at least 30% NRS reduction, and median NRS fell from 6.4 (SD 2.0) to 3.3 (SD 2.2), p<0.0001.
  • The authors conclude the flex mode may improve pain relief and limit dose escalation, with adverse effects in 20.3% of switches, mostly non-serious increased anxiety.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Bienfait F et al. Publisher Chronic painRegional
Review Reg Anesth Pain Med Published 8 Sep 2026
Historical perspective on evolution of neuraxial delivery for pain (1975-2025).
AI-generated abstract summary · verify against the original paper
  • This is a historical commentary, not a primary study, tracing neuraxial therapeutics for pain over roughly the past 50 years.
  • It covers the advances leading to current neuraxially targeted therapies and considers where this line of development may lead.
  • The abstract reports no quantitative results, sample sizes, or comparative outcomes, so it offers a narrative overview rather than evidence of effect.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Yaksh T et al. Publisher Regional
Review Reg Anesth Pain Med Published 8 Sep 2026
Practical guide to intrathecal drug delivery: short-term and long-term management and complications.
AI-generated abstract summary · verify against the original paper
  • This practical guide synthesizes evidence, consensus recommendations, and international clinical experience on intrathecal drug delivery for refractory pain.
  • It covers preimplant evaluation, trialing, pump and catheter selection, perioperative care, early troubleshooting, long-term maintenance, and complication surveillance.
  • It reviews intrathecal opioids, local anesthetics, ziconotide, clonidine, and baclofen, with attention to indication-specific dosing and safety, but reports no pooled quantitative results.
  • It frames outcomes beyond pain intensity, including function, quality of life, and reduced systemic medication use, and addresses cancer and non-cancer populations separately.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Sivanesan E et al. Publisher Chronic painPerioperative medicineRegional
Article Reg Anesth Pain Med Published 8 Sep 2026
Complications leading to device explant in patients with chronic non-cancer pain receiving intrathecal drug delivery.
AI-generated abstract summary · verify against the original paper
  • Retrospective single-center study of 215 patients with chronic non-cancer pain who received intrathecal drug delivery devices between 2009 and 2022, most with PSPS2 (184 patients).
  • The exposure was intrathecal drug delivery, and explant reasons were compared with spinal cord stimulation explant rates from a similar patient population.
  • The explant rate was 26.1%, with device-related infection the leading cause in 9.3% of patients (5.9% of device surgeries) and loss of analgesic efficacy in 5.6%.
  • Infections occurred earlier after implant than other complications, and no demographic or comorbidity factors correlated with explant, per the authors.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Hayek SM et al. Publisher Chronic painPerioperative medicineRegional
Article Reg Anesth Pain Med Published 8 Sep 2026
Implanted intrathecal pump catheter migration rates in the management of cancer-related pain.
AI-generated abstract summary · verify against the original paper
  • Single-center retrospective chart review of 441 cancer patients with intrathecal pumps, of whom 117 had two chest CTs at least 30 days apart.
  • No comparator; catheter migration was defined as movement of one or more vertebral levels between the two imaging studies.
  • Migration occurred in 15.4% (18 of 117), all limited to a single level; revision-requiring migration occurred in 2 of 441 (0.45%).
  • The authors conclude minor migration is common but clinically significant migration is rare with their anchoring and closure techniques, and no demographic factors were associated.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Martinez Alvarez GA et al. Publisher Chronic painRegional
Article Reg Anesth Pain Med Published 8 Sep 2026
Intrathecal bupivacaine monotherapy in patients with chronic refractory localized pain: a case series.
AI-generated abstract summary · verify against the original paper
  • Retrospective case series of five patients with chronic pain and regionally localized pain who had implanted intrathecal devices and received bupivacaine monotherapy.
  • Device duration ranged from over 2 to over 12 years, and two patients had moved from an opioid-bupivacaine combination to bupivacaine alone.
  • All five patients reported at least 50% pain relief and stopped systemic opioids.
  • The authors suggest monotherapy may be effective for localized pain but state that more studies are needed to establish its safety and efficacy.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Hayek SM et al. Publisher Chronic painRegional
Observational Reg Anesth Pain Med Published 8 Sep 2026
Bupivacaine serum concentrations during chronic intrathecal infusion for pain management: an observational single-center study.
AI-generated abstract summary · verify against the original paper
  • A single-center retrospective study of 31 patients, with 162 serial blood samples drawn before pump refills during intrathecal bupivacaine for cancer pain.
  • Serum bupivacaine concentration was examined against daily dose and infusion flow rate, with body mass index also assessed as a factor.
  • Mean serum concentration was 167.7 µg/L (SD 266.2) at a mean daily dose of 39.5 mg/day (SD 31.4), and concentration rose with dose.
  • Higher flow rates stayed independently associated with concentration after adjusting for dose, and the authors conclude exposure is well below the toxicity threshold.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Bienfait F et al. Publisher Chronic painRegional
Review Reg Anesth Pain Med Published 8 Sep 2026
Uncommon indications in chronic pain for intrathecal drug delivery systems: a narrative review of the literature.
AI-generated abstract summary · verify against the original paper
  • This narrative review searched five databases and screened studies with three reviewers, then synthesized them descriptively due to heterogeneity.
  • It examines intrathecal drug delivery systems for less common refractory pain, including spinal cord injury pain, transverse myelitis, diabetic neuropathy, postherpetic neuralgia and craniofacial pain.
  • The authors found the evidence rests mainly on observational studies and small trials, with possible meaningful relief in selected patients but variable magnitude and durability of response.
  • They conclude the evidence is limited, that selective clinical use may contribute to this gap, and that future research is needed to define its role.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Singla P et al. Publisher Chronic painRegional
Article Reg Anesth Pain Med Published 8 Sep 2026
Pain and symptom severity outcomes in patients with cancer before and after intrathecal drug delivery: mixed model analysis in 222 cases.
AI-generated abstract summary · verify against the original paper
  • Retrospective single-center cohort of 435 patients with cancer pain treated with intrathecal drug delivery from 2013 to 2023; 222 met inclusion criteria.
  • Longitudinal Brief Pain Inventory and Condensed Memorial Symptom Assessment Scale scores were compared before and after implantation, with no concurrent comparator group.
  • Over the first 90 days, pain severity, pain interference, and physical symptom scores each declined per day (BPI-SEV -0.014, 95% CI -0.020 to -0.009; BPI-INT -0.020; CMSAS-PHYS -0.004), and 91% stopped systemic opioids.
  • Scores worsened before implantation and improved afterward, and the authors report benefits sustained up to one year.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Odell DW et al. Publisher Chronic painRegional
Meta-analysis Reg Anesth Pain Med Published 8 Sep 2026
Systematic review and meta-analysis of intrathecal drug delivery systems for the treatment of chronic refractory non-cancer pain.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 39 studies (n=2652) in adults with chronic non-cancer pain treated with intrathecal drug delivery.
  • Twenty single-arm comparisons contributed to the pain-intensity meta-analysis at 12 months, so there was no controlled comparator.
  • Pooled pain reduction from baseline was 2.64 (95% CI 2.19 to 3.08), with a 75% probability of exceeding the 2-unit MCID (95% CI 68% to 83%).
  • All studies reported functional and HRQoL improvements, but adverse event reporting was inconsistent and certainty of evidence was low.
PubMed indexed 8 Sep 2026 Imported 9 Nov 2026 Duarte RV et al. Publisher Chronic painRegional
Article Reg Anesth Pain Med Published 4 Sep 2026
Do-not-resuscitate status and regional analgesia utilization for fracture pain: a comfort paradox?
AI-generated abstract summary · verify against the original paper
  • Cross-sectional analysis of National Inpatient Sample adult hospitalizations for rib or hip fractures from 2016 to 2022, including 298,343 rib and 462,796 hip fracture admissions.
  • Compares receipt of regional analgesia by do-not-resuscitate status; regional analgesia was received in 2.9% of rib and 3.0% of hip fracture hospitalizations.
  • Do-not-resuscitate status was linked to lower adjusted odds of regional analgesia for rib fractures (OR 0.76; 95% CI 0.69 to 0.83) but not hip fractures (OR 1.00; 95% CI 0.94 to 1.06).
  • The association was strongest among the least frail rib fracture hospitalizations (OR 0.34; 95% CI 0.25 to 0.48), and the authors call for prospective studies to confirm the findings.
PubMed indexed 4 Sep 2026 Imported 9 Nov 2026 Siddiqui A et al. Publisher Regional
Article Reg Anesth Pain Med Published 4 Sep 2026
Perioperative peripheral nerve blocks for elective below-knee amputations and phantom limb syndrome: an exploratory multicenter retrospective cohort study.
AI-generated abstract summary · verify against the original paper
  • Multicenter retrospective cohort using Epic Cosmos data from 2016 to 2025, including 38,433 adults undergoing elective below-knee amputation.
  • Compared 7,430 patients who received perioperative nerve blocks with 31,003 who did not, examining phantom limb syndrome coded within 12 months.
  • Phantom limb syndrome coding occurred in 18.8% versus 15.1% (absolute difference 3.7%), with Mantel-Haenszel RR 1.24 (95% CI 1.20 to 1.28) after age, sex, and race adjustment.
  • The authors call the findings exploratory, possibly reflecting confounding by indication or differential surveillance, and report shorter length of stay with blocks.
PubMed indexed 4 Sep 2026 Imported 9 Nov 2026 Nguyen EH et al. Publisher Perioperative medicineRegional
Article Reg Anesth Pain Med Published 4 Sep 2026
When gastric point-of-care ultrasound changes management: a research letter.
AI-generated abstract summary · verify against the original paper
  • Secondary analysis of 65 gastric POCUS studies drawn from the data extraction behind a previously published ASRA Pain Medicine narrative review.
  • Studies were sorted by primary purpose: 54 were population or intervention research, 9 were foundational or validation work, and 2 were clinical decision-impact studies.
  • Management-change status was reported or extractable in 8 studies, and all 8 reported at least one change, with rates from 0.4% to 46%.
  • The two clinical decision-impact studies reported change rates of 5.0% and 18.9%, and no included study clearly linked management change to patient-centered outcomes.
PubMed indexed 4 Sep 2026 Imported 9 Nov 2026 Haskins SC et al. Publisher Regional
RCT Reg Anesth Pain Med Published 4 Sep 2026
Single-injection adductor canal block with perineural dexamethasone versus continuous adductor canal catheter for total knee arthroplasty: a randomized controlled trial.
AI-generated abstract summary · verify against the original paper
  • Randomized, participant- and assessor-blinded trial of 94 patients undergoing primary unilateral total knee arthroplasty.
  • Compared a single-injection adductor canal block with perineural dexamethasone against the same block followed by a continuous adductor canal catheter infusing 0.2% ropivacaine for 50 hours.
  • No significant difference in opioid use at 24-48 hours (median 30 mg vs 38.8 mg; 95% CI -22.50 to 7.00 mg; p=0.213), and PACU opioid use was also not significantly different (p=0.081).
  • Catheter-associated buckling occurred in 7% of the continuous group versus 0% of the single-injection group, all transient; the authors concluded the catheter did not reduce opioid use.
PubMed indexed 4 Jun 2026 Imported 9 Nov 2026 Kim DH et al. Publisher PharmacologyRegional
RCT Reg Anesth Pain Med Published 3 Sep 2026
Prolonging peripheral ropivacaine nerve block with an in situ-formed hydrogel carrier: randomized controlled trial in an ovine model.
AI-generated abstract summary · verify against the original paper
  • Randomized, blinded two-period crossover trial in 10 female sheep receiving ultrasound-guided sciatic nerve injections.
  • Compared 200 mg ropivacaine in a poloxamer-alginate in situ-forming hydrogel against 200 mg plain ropivacaine solution.
  • Hydrogel prolonged sensory block (median 60 vs 24 hours) and motor block (median 60 vs 16 hours), with lower early plasma peak (Cmax 558 vs 5101 nmol/L).
  • Histopathology showed more pronounced, persistent tissue degeneration, necrosis and inflammation with the hydrogel, so the authors judged it unclear whether prolonged effect reflected sustained release or toxicity.
PubMed indexed 3 Sep 2026 Imported 9 Nov 2026 Vingen HV et al. Publisher Regional
Review Reg Anesth Pain Med Published 3 Sep 2026
Procedure-specific effects of intravenous lidocaine in adult spine surgery: a systematic review and meta-analysis of randomized controlled trials.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 10 randomized trials of adults undergoing spine surgery, with 655 patients in the 24-hour pain analysis.
  • Perioperative intravenous lidocaine infusion was compared with placebo or standard care.
  • Lidocaine reduced 24-hour pain (MD -0.83; 95% CI -1.36 to -0.30; p=0.002) and opioid consumption (MD -11.64 mg IV morphine equivalents; 95% CI -16.14 to -7.14), with high heterogeneity (I² 89%).
  • A post hoc subgroup analysis found larger pain reduction after instrumented fusion or complex surgery (MD -1.23) than after decompression (MD -0.20), which the authors call hypothesis-generating.
PubMed indexed 3 Sep 2026 Imported 9 Nov 2026 A Felippe V et al. Publisher NeuroRegional
Article Reg Anesth Pain Med Published 2 Sep 2026
When gastric point-of-care ultrasound is indeterminate: an educational review and suggested reporting framework.
AI-generated abstract summary · verify against the original paper
  • This educational review is a focused secondary analysis of the 65 studies from an earlier narrative review of gastric POCUS in medically complex patients.
  • It examined how studies reported scans not performed, scans started but not completed, technically inadequate images, and uncertain results despite visualization.
  • Of the 65 studies, 32 reported at least one indeterminate or non-interpretable exam, 24 reported none, and nine were unclear or non-numeric.
  • The authors state that an indeterminate scan is non-diagnostic and should prompt reliance on the original aspiration-risk assessment or a more cautious plan.
PubMed indexed 2 Sep 2026 Imported 9 Nov 2026 Haskins SC et al. Publisher Regional
Article Pain Physician Published Sep 2026 (day not reported)
Reduction of Serum Substance P and Beta Endorphin in Herpes Zoster After Erector Spinae Plane Block.
AI-generated abstract summary · verify against the original paper
  • Prospective, nonrandomized case-control study comparing herpes zoster patients with healthy age- and sex-matched volunteers; the sample size is not stated in the abstract.
  • Patients received an ultrasound-guided erector spinae plane block at the affected dermatome, with serum sampled before and after blocks.
  • IL-6 and substance P/CGRP levels did not differ significantly between herpes zoster patients and controls.
  • The authors report a significant post-block change (P = 0.009) in substance P and beta-endorphin, but the listed medians (24.0 and 237.8 after, 30.6 before) do not clearly match a decrease.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Lee JY et al. Chronic painRegional
Article Pain Physician Published Sep 2026 (day not reported)
Minimally Invasive Office-Based Protocol Yields Preliminary Improvements in Pelvic Pain and Function.
AI-generated abstract summary · verify against the original paper
  • A retrospective cohort of 2,660 patients with chronic pelvic pain at Pelvic Rehabilitation Medicine centers across the United States, compared at baseline and about 3 months.
  • The protocol was a series of six ultrasound-guided pelvic peripheral nerve blocks and trigger point injections, evaluated without a control group.
  • Pain fell 48.6% (P < 0.001), 55% reached at least 50% pain improvement, and opioid use fell 45.4%, with ED and urgent care visits down 89.4%.
  • The authors conclude the protocol is associated with broad improvements and call for longer-term follow-up against a control group.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Shirkhande A et al. Chronic painRegional
Observational Pain Physician Published Sep 2026 (day not reported)
Effects of Burst Spinal Cord Stimulation Versus Those of Paravertebral Block on Thoracic Subacute Herpetic Neuralgia: A Propensity Score-Matched Retrospective Cohort Study.
AI-generated abstract summary · verify against the original paper
  • Single-center retrospective cohort of 382 patients with thoracic subacute herpetic neuralgia, propensity-matched into 72 pairs of burst-SCS and thoracic paravertebral block recipients.
  • Burst spinal cord stimulation was compared with thoracic paravertebral block on pain, breakthrough pain, touch-evoked pain, sleep, and medication use over 12 months.
  • Burst-SCS showed greater VAS improvement from discharge through 12 months, higher cure rates, and lower postherpetic neuralgia incidence at 3 months, though the abstract gives no effect sizes or CIs.
  • Both procedures relieved pain and improved sleep, and the authors conclude burst-SCS had more favorable outcomes, with no difference in oral morphine equivalent dose.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Zhou XK et al. Chronic painRegional
RCT Pain Physician Published Sep 2026 (day not reported)
The Effect of Unilateral Subcostal Transversus Abdominis Plane Block Applied as Single or Multiple Injections on Pain in Laparoscopic Cholecystectomy.
AI-generated abstract summary · verify against the original paper
  • Prospective, randomized, single-center trial of 90 adults (89 completed) undergoing elective laparoscopic cholecystectomy, allocated to single-injection, multi-injection, or no-block groups.
  • Ultrasound-guided unilateral subcostal TAP block was given as a single injection or as multiple injections, compared with no block.
  • The multi-injection group had the lowest 24-hour tramadol use and lower VAS scores at 1, 6, and 24 hours (P<0.05), with PONV-free rates of 92% vs 64% vs 52% (P=0.007).
  • The authors conclude both block types gave effective analgesia, with the multi-injection technique showing superior pain control and higher patient satisfaction (P<0.001).
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Nihan OMG et al. Chronic painRegional
Article Pain Physician Published Sep 2026 (day not reported)
Peripheral Nerve Stimulation for Intractable Chronic Pain: Real-World Clinical Outcomes, Utilization, and Economic Impact (PNS IMPACT Study).
AI-generated abstract summary · verify against the original paper
  • Hybrid retrospective study of 175 adults with chronic neuropathic pain at one US center, plus national claims data (n = 953).
  • Patients had a PNS trial, and those with at least 50% relief could receive permanent implants; outcomes were compared with baseline, not a control group.
  • Mean NRS-11 pain fell from 7.2 at baseline to 1.7 at 12 months, 1.4 at 24 months, and 2.2 at 36 months (all P < 0.001), with no serious adverse events reported.
  • Pain center office visits fell 54.1% in months 0-12 and 58.9% in months 13-24, with two-year cost reductions totaling $10,271.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Moghim R et al. Chronic painRegional
Article Pain Physician Published Sep 2026 (day not reported)
Local Coverage Determinations for Peripheral Nerve Injections and Procedures for Chronic Pain: Policy Changes, Clinical Limitations, and Health-Equity Implications.
AI-generated abstract summary · verify against the original paper
  • This health-policy analysis compares September 2025 draft Medicare LCDs for peripheral nerve injections in chronic pain with the final policies, and examines their equity implications.
  • The draft policies would have limited coverage mainly to trigeminal neuralgia radiofrequency and certain corticosteroid injections, with lifetime caps; the final policies restored criteria-based coverage for several blocks.
  • Four contractors published materially identical final LCDs, effective October 25, 2026, while participation in the collaborative process was reported separately from final publication.
  • Pudendal, intercostal, ganglion impar, ulnar, and other peripheral-nerve procedures remain noncovered for chronic pain, and the authors highlight access implications of geographically discordant coverage.
PubMed indexed 28 Sep 2026 Imported 9 Nov 2026 Soin A et al. Chronic painRegional
Article Int J Obstet Anesth Published 26 Aug 2026
A decade of global health partnership to advance obstetric anesthesia practices in the Balkans: a retrospective analysis of neuraxial anesthesia and analgesia use at a major teaching hospital in Serbia (2012-2025).
AI-generated abstract summary · verify against the original paper
  • Retrospective single-center analysis of a Serbian teaching hospital's 2012–2025 obstetric anesthesia training partnership; 130 anesthesiologists from 41 hospitals in five countries attended.
  • The intervention was an annual or biennial one-to-two-week hands-on and didactic school covering neuraxial techniques and truncal blocks, with no comparator group.
  • Neuraxial cesarean use rose from 13.8% (2011) to 79.9% (2025), a 4.7% average annual rate of change, P = 0.006; labor analgesia rose from 2.0% to 14.1%, P < 0.001.
  • The authors conclude the partnership supported local training capacity and that neuraxial use increased at this center during the study period.
PubMed indexed 10 Sep 2026 Imported 9 Nov 2026 Pujic BP et al. Publisher ObstetricRegional
Newer Older